Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Arianna Rizzo
Institutions:
Institut d'Investigació Biomédica de Bellvitge,
Universitat de Barcelona
Observed institutions:
Universitat de València,
Institut d'Investigació Biomédica de Bellvitge,
Universitat de Barcelona
ORCID:
0000-0003-4404-194X
Observed ORCID:
0000-0003-4404-194X
OpenAlex ID:
A5003581282
Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability
2022
·
Marjorie R. Levinstein
, Meghan L. Carlton
, et al.
·
Biological Psychiatry
·
54
PDF
In vivo photopharmacology with light-activated opioid drugs
2023
·
Shannan P. McClain
, Xiang Ma
, et al.
·
Neuron
·
44
PDF
In vivo photopharmacology with a caged mu opioid receptor agonist drives rapid changes in behavior
2023
·
Xiang Ma
, Desiree A. Johnson
, et al.
·
Nature Methods
·
44
PDF
Parvalbumin Interneurons and Perineuronal Nets in the Hippocampus and Retrosplenial Cortex of Adult Male Mice After Early Social Isolation Stress and Perinatal NMDA Receptor Antagonist Treatment
2021
·
Patrycja Klimczak
, Arianna Rizzo
, et al.
·
Frontiers in Synaptic Neuroscience
·
33
PDF
Converging circuits between pain and depression: the ventral tegmental area as a therapeutic hub
2023
·
Montse Flores-García
, Arianna Rizzo
, et al.
·
Frontiers in Pharmacology
·
29
PDF
The dopaminergic effects of esketamine are mediated by a dual mechanism involving glutamate and opioid receptors
2025
·
Arianna Rizzo
, Maria Zelai Garçon-Poca
, et al.
·
Molecular Psychiatry
·
25
PDF
Essential role of P-glycoprotein in the mechanism of action of oliceridine
2022
·
Emilya Ventriglia
, Arianna Rizzo
, et al.
·
Neuropsychopharmacology
·
17
PDF
Exploring the Pharmacological and Behavioural Effects of (s)-ketamine on the Dopaminergic System
2023
·
Arianna Rizzo
, Zelai Garçon-Poca
, et al.
·
IBRO Neuroscience Reports
PDF
Show more works
View as search
Works count:
8
Citation count:
246
H-index:
7
I10-index:
7
Year
Topic
Type